Device Trial Radar · NCT07775469
Comparison Study for Hemodynamic Parameters Generated by Vitalstream Relative to Appropriate Gold Standard References in Different Clinical Settings, (OR, EP Lab Etc.).
Last checked: Nov 20, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Aug 24, 2026
Primary completion
Aug 24, 2027
Study completion Feb 1, 2028
Sponsor
- Lead sponsor
- CareTaker Medical LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 20, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of the proposed study is to test the capability of the Vitalstream monitor's continuous blood pressure tracking ability against Gold Standard.
Conditions
- No Specific Conditions Are Being Examined
Interventions
VitalstreamDevice
Non-invasive BP monitoring. No intervention
Primary outcomes
What the sponsor says the trial is designed to measure.
- BP Reading AgreementTime frame: 30 minutes to 24 hours
1 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.